Bluejay Investor Presentation Deck

Management & Advisors: Leadership, Diagnostic & Product Launch Expertise ●●● Indranil "Neil" Dey CEO and Co-founder enneth Fisher Chief Financial Officer Jason Cook Chief Technology Officer Kevin Vance Chief Commercial Officer Edwin Rule, VP Regulatory, Quality, Compliance Mark Feinberg Chief Medical Advisor bluejay DIAGNOSTICS IMPATH The Cancer Information Company Involved in introducing Her2neu test for Herceptin (>$1.2 billion revenue), Lead numerous global teams • Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary, MBA (Fulbright Scholar) from Cambridge University, UK ● ● ● ● ● ● ● Responsible for finance, investor relations, accounting and administrative operations with support to commercial/BD BA, Business Administration, Isenberg School of Management, UMass Amherst; New England School for Financial Studies. CPA Responsible for Bluejay's product development and manufacturing 15+ years in POC/ diagnostics product development, Ph.D. in Biomedical Engineering, University of Texas at Austin Responsible for Regulatory, Quality, Compliance with support to the Symphony System product development team. • BS, Mechanical Engineering, Northeastern U.; MS, Marketing/Technological Innovation, WPI, ASQ Six Sigma Green Belt ● ● In charge of Bluejay's worldwide direct sales and strategic partnerships. Prior Chief BD Executive for Vibra Healthcare BS, Industrial Engineering & Operations Research from UMass Amherst; MBA, Western New England University • Guide Bluejay's clinical development programs, provide strategic medical and scientific leadership Associate Professor, Harvard Medical School/Cardiovascular, Brigham & Women's; Medical College of Pennsylvania 60 TEXAS The University of Texas at Austin East Boston Savings Bank FRESENIUS MEDICAL CARE Brigham and Women's Hospital Founding Member, Mass General Brigham HEALTHCARE Copyright ©2022 Bluejay Diagnostics, Inc. All rights reserved in all slides | September 2022 16

View entire presentation